A new study shows the Pfizer-BioNTech vaccine remains 90% effective at preventing COVID-19 hospitalizations for up to six months after being fully vaccinated, even with the more transmissible delta ...
To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...
Pfizer released additional data about its pill to treat COVID-19 that shows it was effective in preventing hospitalization and death when taken by people with mild to moderate illness within a few ...
WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% as the drug-maker joins the race to bring the first ...
Pfizer said Tuesday morning that final trial studies still show its experimental COVID-19 pill significantly reduced the risk of hospitalization or death linked to the virus, by 89%. The company also ...
Pfizer says kid-size doses of its COVID-19 vaccine are safe and nearly 91% effective at preventing infections in elementary school children. Details of the study were posted online Friday. FDA ...
A new preprint study suggests that Moderna’s COVID-19 vaccine may be significantly more effective against symptomatic disease from the delta variant compared to Pfizer-BioNTech’s vaccine, while the ...
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results